These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1062 related articles for article (PubMed ID: 19628650)

  • 21. The effect of alfacalcidiol and metformin on metabolic disturbances in women with polycystic ovary syndrome.
    Figurová J; Dravecká I; Petríková J; Javorský M; Lazúrová I
    Horm Mol Biol Clin Investig; 2017 Mar; 29(3):85-91. PubMed ID: 28157691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The lipid accumulation product is associated with impaired glucose tolerance in PCOS women.
    Wehr E; Gruber HJ; Giuliani A; Möller R; Pieber TR; Obermayer-Pietsch B
    J Clin Endocrinol Metab; 2011 Jun; 96(6):E986-90. PubMed ID: 21470992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
    Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
    Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.
    Ehrmann DA; Liljenquist DR; Kasza K; Azziz R; Legro RS; Ghazzi MN;
    J Clin Endocrinol Metab; 2006 Jan; 91(1):48-53. PubMed ID: 16249284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients.
    Karadağ C; Yoldemir T; Yavuz DG
    J Obstet Gynaecol Res; 2018 Feb; 44(2):270-277. PubMed ID: 29094433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.
    Hahn S; Haselhorst U; Tan S; Quadbeck B; Schmidt M; Roesler S; Kimmig R; Mann K; Janssen OE
    Exp Clin Endocrinol Diabetes; 2006 Nov; 114(10):577-83. PubMed ID: 17177140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities.
    Figurová J; Dravecká I; Javorský M; Petríková J; Lazúrová I
    Wien Klin Wochenschr; 2016 Sep; 128(17-18):641-8. PubMed ID: 25787215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low serum 25(OH)D levels are assocıated to hıgher BMI and metabolic syndrome parameters in adult subjects in Turkey.
    Tosunbayraktar G; Bas M; Kut A; Buyukkaragoz AH
    Afr Health Sci; 2015 Dec; 15(4):1161-9. PubMed ID: 26958017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of vitamin D concentration with metabolic and hormonal indices in women with polycystic ovary syndrome presenting abdominal and gynoidal type of obesity.
    Kozakowski J; Kapuścińska R; Zgliczyński W
    Ginekol Pol; 2014 Oct; 85(10):765-70. PubMed ID: 25546928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review.
    Menichini D; Facchinetti F
    Gynecol Endocrinol; 2020 Jan; 36(1):1-5. PubMed ID: 31187648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metabolic syndrome in young Korean women with polycystic ovary syndrome.
    Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S243-6. PubMed ID: 17610984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatty liver index in polycystic ovary syndrome.
    Lerchbaum E; Gruber HJ; Schwetz V; Giuliani A; Möller R; Pieber TR; Obermayer-Pietsch B
    Eur J Endocrinol; 2011 Dec; 165(6):935-43. PubMed ID: 21937505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.
    Legro RS; Kunselman AR; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 1999 Jan; 84(1):165-9. PubMed ID: 9920077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome.
    Möhlig M; Weickert MO; Ghadamgahi E; Arafat AM; Spranger J; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2008 Apr; 158(4):517-23. PubMed ID: 18362299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
    Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E
    J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome.
    Fulghesu A; Magnini R; Portoghese E; Angioni S; Minerba L; Melis GB
    J Adolesc Health; 2010 May; 46(5):474-81. PubMed ID: 20413084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
    Wan DH; Fan P; Bai H; Song Q; Liu HW
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.
    Münzker J; Hofer D; Trummer C; Ulbing M; Harger A; Pieber T; Owen L; Keevil B; Brabant G; Lerchbaum E; Obermayer-Pietsch B
    J Clin Endocrinol Metab; 2015 Feb; 100(2):653-60. PubMed ID: 25387259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.